Abstract C56: NCCTG phase I trial of everolimus (RAD001) and temozolomide (TMZ) in combination with radiation therapy (RT) in newly diagnosed glioblastoma multiforme (GBM) patients
Keyword(s):
Phase I
◽
2011 ◽
Vol 81
(2)
◽
pp. 468-475
◽
2016 ◽
Vol 34
(15_suppl)
◽
pp. e13518-e13518
2007 ◽
Vol 69
(3)
◽
pp. 825-830
◽
2011 ◽
Vol 81
(4)
◽
pp. 1066-1074
◽
2005 ◽
Vol 23
(16_suppl)
◽
pp. 1570-1570
◽